IFM is a biopharmaceutical company that develops and commercializes small molecule therapies for the treatment of cancer and inflammatory disorders... Read more
IFM is a biopharmaceutical company that develops and commercializes small molecule therapies for the treatment of cancer and inflammatory disorders... Read more
News
Mar 15, 2024
Medthority
IFM Therapeutics: Novartis acquires IFM Due and its cGAS-STING program .
Mar 13, 2024
The Business Journals: Boston
IFM Therapeutics: Novartis acquires Boston immunotherapy startup
Dec 08, 2021
The Business Journals
IFM Therapeutics: Serial entrepreneur, former IFM CEO launches immuno-oncology startup
Dec 01, 2021
MarketScreener
IFM Therapeutics: IFM Therapeutics Announces Extension of Collaboration Agreement for cGAS-STING Subsidiary, IFM Due
Jan 28, 2020
pm360online
IFM: IFM Therapeutics
The immune-system focused R&D company brings in Michael Cooke
Dec 02, 2019
FinSMEs
IFM: IFM Therapeutics Raises $55.5M in Financing
Dec 02, 2019
BioPortfolio
IFM: IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator
Dec 02, 2019
BioSpace
IFM: Following Two Novartis Deals, IFM Therapeutics Launches Third Subsidiary and Incubator
Nov 21, 2019
MarketScreener
IFM Therapeutics: New Research Demonstrates Second Direct Link Between Inflammasome Activation and Alzheimer's Disease
Sep 06, 2019
The Pharma Letter
IFM Therapeutics: Novartis enters option and deal with IFM Therapeutics, worth up to $840 million
IFM Therapeutics Competitors
1
2
3
4
5
6
7
8
9